CDT funding
The University of Nottingham has won funding for four new centres that will train the brightest young postgraduates to tackle pressing global challenges, and keep the UK at the cutting edge of scientific research.
The Centres of Doctoral Training (CDTs), which are funded by the Engineering and Physical Sciences Research Council (EPSRC), were announced today (22 Nov) by Universities and Science Minister, David Willetts.
The University is also involved in three additional centres that are led by other institutions. All these centres will provide research students with an outstanding research environment, exceptional resources, industry engagement and access to unrivalled training opportunities.
The seven CDTs – worth a total in excess of £30m – will nurture the next generation of technological leaders and are targeted at areas vital to economic growth.
A total of 1,000 partners will be involved in the centres across the UK, leveraging approximately £250m of additional support. This is the UK's largest investment in post graduate training in engineering and physical sciences. It will fund over seventy new CDTs, spread across 24 UK universities and will train over 3,500 postgraduate students.
Professor Saul Tendler, Pro-Vice-Chancellor for Research at the University said “I am delighted with this very strong performance in this key competition; Nottingham leading four centres is an outstanding result, especially given our additional partnership with three other centres. It is especially pleasing that our new CDTs recognise and support our investments and key priorities in sustainable chemistry, advanced therapeutics, digital economy and additive manufacturing."
“Nottingham currently trains over 3,000 postgraduate research students across seven campuses in the UK, China and Malaysia, and is committed to ensuring that EPSRC CDTs are major flagship elements of our global postgraduate community.”
Professor Cameron Alexander in the School of Pharmacy will lead the CDT in Advanced Therapeutics and Nanomedicines, developing scientists who will be adaptable and productive in a sector evolving from extensive recent change. The pharmaceutical sector is a vital part of the UK economy and for it to remain innovative on a global scale the most important requirement is the provision of highly skilled and trained people.
Click here for the full story
Posted on Wednesday 27th November 2013